Trial
NCT00090779
Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID); Adult AIDS Clinical Trials Group
Condition
HIV Infections
Intervention
Emtricitabine/ tenofovir disoproxil fumarate
Why stopped
The DSMB concluded that the findings regarding the primary analysis would persist and that no additional study goals would be achieved by continuing the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-11